Piper Heartland Healthcare Capital

About Piper Heartland Healthcare Capital

Piper Heartland Healthcare Capital aligns the knowledge, expertise, and capital of Piper Sandler with the interests of our limited partners to invest in innovative healthcare companies at key moments in their growth path. This combination—knowledge, expertise, capital, and alignment—allows Piper Heartland Healthcare Capital to pursue proprietary investment opportunities and deliver exceptional potential returns for investors. The Piper Heartland Healthcare Crossover Fund is a dedicated healthcare investment fund with over $200 million in committed capital, that focuses on innovative companies with near-term public market prospects, driven by experienced management teams and backed by highly respected investment partners. Building on the industry knowledge and capital markets expertise of Piper Sandler’s leading healthcare banking and research platforms, the Piper Heartland Healthcare Crossover Fund invests primarily in the biotech, med-tech, and healthcare information sectors.
People
  • Matt Hemsley, CEO of Piper Heartland Healthcare Capital